RB anthocyanin also enhanced insulin sensitivity, upregulated adiponectin expression, downregulated inflammatory cytokines, and altered AMPK phosphorylation, which is a T2DM therapeutic target [264]. The gene discussed is ADIPOQ; the disease is type 2 diabetes mellitus.